Oxford BioMedica
Oxford BioMedica has established a platform of technologies in gene delivery and immunotherapy, protected by an extensive intellectual property estate. Through in-house and collaborative development, the Company has a broad pipeline of gene-based product candidates for the treatment of age-related or inherited neurodegenerative and ocular diseases. In addition, Oxford BioMedica and its collaborators are developing novel targeted therapies and therapeutic vaccines to treat multiple types of cancer.
| Type: |
NORMAL |
| Address: |
Medawar Centre, Robert Robinson Avenue, The Oxford Science Park, Oxford, OX4 4GA |
| Website: |
www.oxfordbiomedica.co.uk |